. 2019 Jun 15;7(3):188–202.

Table 1.

Description of clinical and pathological characteristics of prostate cancer specimens used on TMA

TMA Description	Clinicopathlogical Parameters	# of Cases
Specimens	BPH	34
Specimens	Prostate cancer	165
Tumor grade	Gleason ≤ 6	33
	Gleason 7	100
	Gleason ≥ 8	32
Clinical Stage	Stage I	3
	Stage II	86
	Stage III	47
	Stage IV	18
	Unknown	11
Metastatic prostate cancer	Organ Confined	141
	Lymph node/bone Metastasis	13
	Unknown	11
Smoking	Tobacco/cigar/others	52
	Non-smoking	56
	Unknown	57
Recurrence	Local/Distal Recurrence	31
	No Recurrence	82
	Unknown	52
PSA	< 10 ng/ml	3
	10-20 ng/ml	4
	> 20 ng/ml	66
Age range (years)	BPH	57-81
Age range (years)	Prostate cancer	41-75